POCT Market in Europe 2015-2019

  • ID: 3616227
  • Report
  • Region: Europe
  • 72 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • A. Menarini Diagnostics
  • Alere
  • Bio-Rad Laboratories
  • Helena Laboratories
  • Life Technologies
  • Randox Laboratories
  • MORE
About POCT Market in Europe

POCT is the fastest growing segment of laboratory diagnostics in Europe. It is performed using electronic and non-electronic devices that range from reaction strips to bulky devices. These devices replace a series of laboratory experiments and reduce the turnaround time. POCT diagnostic devices can be categorized into hand-held and near-bedside monitoring devices. The hand-held POCT devices are small, offering mobility while the near-bedside POCT devices are larger and complex. For both the devices, quality control and calibration functionality are checked before performing the tests.

The analysts forecast the POCT market in Europe to grow at a CAGR of 4.07% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the point-of-care testing (POCT) market in Europe for the period 2015-2019. To calculate the market size, the report considers the revenue generated from sales of POCT diagnostic devices, including instruments and consumables

The market is divided into the following segments based on application:
- Blood glucose testing
- Infectious diseases testing
- Cardiac markers testing
- Coagulation testing
- Pregnancy and fertility testing
- Electrolyte testing
- Tumor markers testing
- Urinalysis
- Cholesterol testing

The report, POCT Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott Laboratories
- Alere
- Bayer Healthcare
- LifeScan
- Roche Diagnostics
- Siemens

Other prominent vendors
- Abaxis
- A. Menarini Diagnostics
- Acon Laboratories
- BD
- Beckman Coulter
- Bio-Rad Laboratories
- Cepheid
- Chembio Diagnostic Systems
- Clarity Diagnostics
- DiagCor
- Helena Laboratories
- Hologic
- Life Technologies
- Landwind Medical
- Mindray
- i-Sens
- Nipro Diagnostics
- Randox Laboratories
- Span Diagnostics
- Snibe Diagnostics
- Sysmex
- Trivitron Healthcare
- URIT

Market drivers
- Patient-driven demand
- For a full, detailed list, view the full report

Market challenges
- Direct-to-consumer genetic testing
- For a full, detailed list, view the full report

Market trends
- Government initiatives for quality improvement
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • A. Menarini Diagnostics
  • Alere
  • Bio-Rad Laboratories
  • Helena Laboratories
  • Life Technologies
  • Randox Laboratories
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: POCT testing: Overview
  • Conformité Européene (CE) approval in Europe
  • POCT market scenario in Europe
PART 07: Market segmentation by application
  • Blood glucose testing market in Europe
  • Infectious diseases testing market in Europe
  • Cardiac markers testing market in Europe
  • Coagulation testing market in Europe
  • Blood gas and electrolytes testing market in Europe
  • Pregnancy and fertility testing market in Europe
  • Tumor markers testing market in Europe
  • Cholesterol testing market in Europe
  • Urinalysis market in Europe
PART 08: Market drivers
  • Patient-driven demand
  • Coverage of POCT devices in developed countries
  • Technological innovations
  • Increased healthcare spending
PART 09: Impact of drivers

PART 10: Market challenges
  • Direct-to-consumer (DTC) genetic testing
  • Pricing structure of European healthcare
  • Threat from low-cost products
  • Technology limitations
PART 11: Impact of drivers and challenges

PART 12: Market trends
  • Government initiatives for quality improvement
  • Patient-centered healthcare by digital technology
  • Growing popularity of portable POCT products
  • Next-generation sequencing and DNA microarrays
PART 13: Vendor landscape
  • Competitive scenario
  • Abbott Diagnostics
  • Alere
  • LifeScan
  • Roche Diagnostics
  • Siemens Diagnostics
  • Other prominent vendors
PART 14: Key vendor analysis
  • Abbott Diagnostics
  • Alere
  • LifeScan
  • Roche Diagnostics
  • Siemens Healthcare
PART 15: Appendix
  • List of abbreviations
PART 16: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: POCT market in Europe 2015-2019 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Difference between diagnostic test and laboratory testing process
Exhibit 05: Approval of self-testing IVD
Exhibit 06: Market share of POCT market in Europe by country
Exhibit 07: Segmentation of POCT market by application
Exhibit 08: Blood glucose testing market in Europe 2014-2019 ($ millions)
Exhibit 09: Infectious disease testing market in Europe 2014-2019 ($ millions)
Exhibit 10: Cardiac markers testing market in Europe 2014-2019 ($ millions)
Exhibit 11: Coagulation testing market in Europe 2014-2019 ($ millions)
Exhibit 12: Blood gas and electrolytes testing market in Europe 2014-2019 ($ millions)
Exhibit 13: Pregnancy and fertility testing market in Europe 2014-2019 ($ millions)
Exhibit 14: Tumor marker testing market in Europe 2014-2019 ($ millions)
Exhibit 15: Cholesterol testing market in Europe 2014-2019 ($ millions)
Exhibit 16: Urinalysis market in Europe 2014-2019 ($ millions)
Exhibit 17: POCT market share by products
Exhibit 18: Impact of drivers
Exhibit 19: Impact of drivers and challenges
Exhibit 20: Abbott Diagnostics: Key takeaways
Exhibit 21: Alere: Key takeaways
Exhibit 22: LifeScan: Key takeaways
Exhibit 23: Roche Diagnostics: Key takeaways
Exhibit 24: Siemens Diagnostics: Key takeaways
Exhibit 25: Abbott Diagnostics: key business offerings
Exhibit 26: Alere: Business Segmentation by revenue 2014
Exhibit 27: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 28: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
Exhibit 29: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 30: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 31: Roche Diagnostics: Geographical segmentation by revenue 2014
Exhibit 32: Siemens Healthcare: Business segmentation
Exhibit 33: Siemens Healthcare: Geographical segmentation by revenue 2014
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • A. Menarini Diagnostics
  • Alere
  • Bio-Rad Laboratories
  • Helena Laboratories
  • Life Technologies
  • Randox Laboratories
  • MORE
New Report Released: - POCT Market in Europe 2015-2019

The author of the report recognizes the following companies as the key players in the POCT Market in Europe: Abbott Laboratories, Alere, Bayer Healthcare, LifeScan, Roche Diagnostics and Siemens.

Other Prominent Vendors in the market are: Abaxis, A. Menarini Diagnostics, Acon Laboratories, BD, Beckman Coulter, Bio-Rad Laboratories, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, DiagCor, Helena Laboratories, Hologic, Life Technologies, Landwind Medical, Mindray, i-Sens, Nipro Diagnostics, Randox Laboratories, Span Diagnostics, Snibe Diagnostics, Sysmex, Trivitron Healthcare, and URIT.

Commenting on the report, an analyst from the research team said: “The increasing use of POCT devices is forcing governments to monitor the quality of these devices to ensure patient safety. Norway leads in POCT quality control. The Norwegian Center for External Quality Assurance in Primary Health Care (NOKULAS) aims to produce information concerning the quality of laboratory equipment.”

According to the report, high prevalence of diseases and increased awareness about diseases and the advances in medicine are driving individuals to opt for preventative and control measures.

Further, the report states that the reimbursement structure is not uniform in the EU as each member state has its own policies for reimbursement approval by public or private insurance companies or both.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Abbott Laboratories
- Alere
- Bayer Healthcare
- LifeScan
- Roche Diagnostics
- Siemens
- Abaxis
- A. Menarini Diagnostics
- Acon Laboratories
- BD
- Beckman Coulter
- Bio-Rad Laboratories
- Cepheid
- Chembio Diagnostic Systems
- Clarity Diagnostics
- DiagCor
- Helena Laboratories
- Hologic
- Life Technologies
- Landwind Medical
- Mindray
- i-Sens
- Nipro Diagnostics
- Randox Laboratories
- Span Diagnostics
- Snibe Diagnostics
- Sysmex
- Trivitron Healthcare
- URIT.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll